KAREN NARUM: Open Payments
NPI 1851462121 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 14 payments from 9 companies in 2025. Trend: 2023 $455 · 2024 $192 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $49 |
| SANOFI PASTEUR INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
| Smith+Nephew, Inc. | 1 | $17 |
Products named: FLUZONE HIGH-DOSE, AIRSUPRA, OTEZLA, TZIELD, GVOKE HYPOPEN, GARDASIL 9, MOUNJARO, Cologuard Collection Kit.
Industry payments across AZ — which companies pay providers there.
